乳腺癌内分泌治疗患者的同期症状网络分析

doi:10.3761/j.issn.1672-9234.2024.09.018

Abstract

Abstract:

Objective To investigate the incidence and the degree of symptom distress in breast cancer patients undergoing endocrine therapy，and to construct a contemporaneous symptom network to identify the core symptoms and symptom clusters，so as to provide references for precise symptom management. Methods A convenience sampling method was used to select breast cancer patients undergoing endocrine therapy in outpatient clinics and day wards of a tertiary hospital in Baoding City from February 2023 to November 2023，and a total of 330 patients were included. The Chinese Breast Cancer Prevention Trial Symptom Scale（C-BCPT） was used to assess the symptoms of the patients. The principal component analysis was used to extract the symptom clusters，and the symptom network was construct by R language，and the centrality index was calculated. Results Symptoms that distressed more than 50% of patients were fatigue （60.0%），weight gain （60.0%），hot flashes（60.0%），and joint pain（52.1%），which were also the top four symptoms with the highest degree of distress. Cognitive/fatigue symptom cluster，musculoskeletal/vasomotor symptom cluster，and sexual problems symptom cluster were extracted. In the symptom network，difficult to concentrate（rS=1.09） was a symptom with the highest strength，cognitive/fatigue symptom cluster（rS=0.92） was a symptom cluster with the highest average strength，and the top three symptoms with the highest bridge strength were fatigue（rBS=0.29），weight gain（rBS=0.23），and lack of interest in sex（rBS=0.22）. Conclusion There are various symptoms in breast cancer patients undergoing endocrine therapy. Difficulty in concentration is the core symptom for breast cancer patients，the cognitive/fatigue symptom cluster is the core symptom cluster，fatigue，weight gain，and lack of interest in sex are the bridge symptoms in the network analysis. Healthcare professionals can develop precise interventions for the core symptoms，symptom clusters and bridge symptoms so as to improve symptom management efficiency and outcomes.

Key words: Breast cancer, Endocrine therapy, Symptom network, Core symptoms, Bridge symptoms, Symptom management

HE Xiaoge, LI Huanxi, LU Qian, LIU Chunlei, KE Sangsang. Contemporaneous symptom network analysis in breast cancer patients undergoing endocrine therapy[J].Chinese Journal of Nursing Education, 2024, 21(9): 1141-1146.

Figures/Tables 5

Table 1

Table 2

Table 3

Figure 1

Figure 2

References 27

[1]	Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality world-wide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263.
[2]	Krauss K, Stickeler E. Endocrine therapy in early breast cancer[J]. Breast Care, 2020, 15(4):337-346. doi: 10.1159/000509362 pmid: 32982643
[3]	Early Breast Cancer Trialists’ Collaborative Group(EBCTCG). Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression:a patient-level meta-analysis of 7 030 women from four randomised trials[J]. Lancet Oncol, 2022, 23(3):382-392.
[4]	Rosenberg SM, Stanton AL, Petrie KJ, et al. Symptoms and symptom attribution among women on endocrine therapy for breast cancer[J]. Oncologist, 2015, 20(6):598-604. doi: 10.1634/theoncologist.2015-0007 pmid: 25933930
[5]	Kim HJ, McGuire DB, Tulman L, et al. Symptom clusters:concept analysis and clinical implications for cancer nursing[J]. Cancer Nurs, 2005, 28(4):270-284.
[6]	文翠菊, 王玥妮, 孙红娟, 等. 芳香化酶抑制剂治疗期间乳腺癌患者症状群对生活质量的影响[J]. 中华护理杂志, 2021, 56(8):1201-1207. doi: 10.3761/j.issn.0254-1769.2021.08.013
	Wen CJ, Wang YN, Sun HJ, et al. Symptom clusters and the effects on quality of life among breast cancer patients receiving aromatase inhibitors[J]. Chin J Nurs, 2021, 56(8):1201-1207. doi: 10.3761/j.issn.0254-1769.2021.08.013
[7]	Li HJ, Sereika SM, Marsland AL, et al. Symptom clusters in women with breast cancer during the first 18 Months of adjuvant therapy[J]. J Pain Symptom Manage, 2020, 59(2):233-241.
[8]	Jing F, Zhu Z, Qiu JJ, et al. Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients:a network analysis[J]. Front Oncol, 2023,13:1081786.
[9]	杨中方, 朱政, 胡雁, 等. 症状网络在症状管理中的应用进展[J]. 护理学杂志, 2022, 37(5):91-94.
	Yang ZF, Zhu Z, Hu Y, et al. A review of network approach in symptom management[J]. J Nurs Sci, 2022, 37(5):91-94.
[10]	朱政, 余骏雯, 杨中方, 等. 症状同期网络的分析方法介绍及R软件实现[J]. 护士进修杂志, 2023, 38(24):2235-2239.
[11]	Tsai CF, Tsai PS, Liu CL, et al. Psychometric evaluation of the Chinese breast cancer prevention trial symptom scale[J]. Cancer Nurs, 2018, 41(4):E18-E30.
[12]	李京连, 仲丽芸, 陆朋玮, 等. 开颅术后胶质瘤患者症状群及前哨症状的研究[J]. 护士进修杂志, 2023, 38(24):2303-2307.
[13]	陈庆梅, 崔妙玲, 麻月娥, 等. 慢性阻塞性肺疾病急性加重期患者症状群及前哨症状的调查研究[J]. 中华护理杂志, 2022, 57(23):2891-2897. doi: 10.3761/j.issn.0254-1769.2022.23.011
[14]	余骏雯, 朱政, 胡天天, 等. 症状网络的特异性指标[J]. 护士进修杂志, 2023, 38(24):2229-2234,2245.
	Yu JW, Zhu Z, Hu TT, et al. Specificity indices of symptom network[J]. J Nurses Train, 2023, 38(24):2229-2234,2245.
[15]	Castro D, Ferreira F, de Castro I, et al. The differential role of central and bridge symptoms in deactivating psychopatholo-gical networks[J]. Front Psychol, 2019,10:2448.
[16]	Wen H, Zhu Z, Hu TT, et al. Unraveling the central and bridge psychological symptoms of people living with HIV:a network analysis[J]. Front Public Health, 2022,10:1024436.
[17]	Haslbeck JMB, Waldorp LJ. How well do network models predict observations? On the importance of predictability in network models[J]. Behav Res Meth, 2018, 50(2):853-861.
[18]	Epskamp S, Borsboom D, Fried EI. Estimating psychological networks and their accuracy:a tutorial paper[J]. Behav Res Methods, 2018, 50(1):195-212. doi: 10.3758/s13428-017-0862-1 pmid: 28342071
[19]	荆凤, 邢唯杰. 乳腺癌患者内分泌治疗相关症状及非药物干预的研究进展[J]. 中华护理杂志, 2021, 56(4):635-640. doi: 10.3761/j.issn.0254-1769.2021.04.027
	Jing F, Xing WJ. Review of symptoms and non-pharmacolo-gical interventions among breast cancer survivors undergoing adjuvant endocrine therapy[J]. Chin J Nurs, 2021, 56(4):635-640. doi: 10.3761/j.issn.0254-1769.2021.04.027
[20]	Wu LM, Amidi A. Cognitive impairment following hormone therapy:current opinion of research in breast and prostate cancer patients[J]. Curr Opin Support Palliat Care, 2017, 11(1):38-45.
[21]	Yamamoto S, Masutani E, Arao H. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy[J]. Breast Cancer, 2020, 27(4):670-682. doi: 10.1007/s12282-020-01062-7 pmid: 32114664
[22]	国家癌症中心,中国药师协会肿瘤专科药师分会. 乳腺癌内分泌治疗药物药学服务指南(2023版)[J]. 中华肿瘤杂志, 2023, 45(10):834-862.
	National Cancer Center, Oncology Specialty Pharmacist Subco-mmittee, Chinese Pharmacists Association. Guidelines for phar-maceutical care of endocrine therapeutics for breast cancer(2023 edition)[J]. Chin J Oncol, 2023, 45(10):834-862.
[23]	杜华, 潘发明, 丁萍, 等. 育龄期乳腺癌术后患者性功能障碍状况及其影响因素研究[J]. 中华肿瘤防治杂志, 2021, 28(22):1742-1748.
[24]	Zhu YH, Cohen SM, Rosenzweig MQ, et al. Symptom map of endocrine therapy for breast cancer:a scoping review[J]. Cancer Nurs, 2019, 42(5):E19-E30.
[25]	Zhu Z, Sun YL, Kuang Y, et al. Contemporaneous symptom networks of multidimensional symptom experiences in cancer survivors:a network analysis[J]. Cancer Med, 2023, 12(1):663-673.
[26]	Jones PJ, Ma RF, McNally RJ. Bridge centrality:a network approach to understanding comorbidity[J]. Multivariate Behav Res, 2021, 56(2):353-367.
[27]	Kaiser T, Herzog P, Voderholzer U, et al. Unraveling the como-rbidity of depression and anxiety in a large inpatient sample:network analysis to examine bridge symptoms[J]. Depress Anxiety, 2021, 38(3):307-317. doi: 10.1002/da.23136 pmid: 33465284

Contemporaneous symptom network analysis in breast cancer patients undergoing endocrine therapy

HTML

PDF(PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 27

Related Articles 7

Metrics

Comments

Recommended 10

[1]	ZOU Yang, TONG Dongtong, YANG Wenjuan, LIU Min, ZHANG Haiyan, XIE Lunfang. A scoping review of research on the health information needs of breast cancer patients [J]. Chinese Journal of Nursing Education, 2024, 21(5): 627-633.
[2]	WANG Meng, ZHANG Xiaoqing, LI Jiaxin, WAN Yinglu. Meta synthesis of qualitative studies on cancer risk perception in first-degree relatives of breast cancer patients [J]. Chinese Journal of Nursing Education, 2024, 21(1): 104-109.
[3]	LI Siqin, LU Hong, WU Manbo, LI Huijun, GAO Jidong, WANG Mengying, CHEN Lingmei, CHE Meiyue. Analysis of learned helplessness status and influencing factors in breast cancer patients [J]. Chinese Journal of Nursing Education, 2024, 21(1): 68-72.
[4]	LÜ Zhanyang, YOU Guomei, TAO Siyi. Progress in symptom network application in symptom management of cancer [J]. Chinese Journal of Nursing Education, 2023, 20(7): 891-896.
[5]	WANG Qi, ZHAO Pei, ZHANG Hongmei, GUO Yuanzhi. Research progress on common problems and improvement strategies of endocrine therapy compliance in breast cancer patients [J]. Chinese Journal of Nursing Education, 2023, 20(3): 372-376.
[6]	WEI Tingting, WANG Ying, WU Peipei, QIANG Wanmin, LI Xia, LI Miaomiao, CHEN Yuhong, WANG Qing, WANG Yan, REN Hailing. Development of a nursing training program of breast cancer-related lymphedema for nurses [J]. Chinese Journal of Nursing Education, 2023, 20(11): 1335-1341.
[7]	HE Chun-yan, WEI Ya-nan, LU Ying, CHANG Shu-ying. The effects of the perceived stress and perceived professional benefits on mental health of nurses in depart-ments of mammary oncology [J]. Chinese Journal of Nursing Education, 2019, 16(11): 867-871.